Dyadic International (DYAI) Receivables - Other (2017 - 2025)
Dyadic International (DYAI) posted Receivables - Other of $23213.0 for Q1 2025, down 4.27% sequentially from $24248.0 in Q4 2024, and up 52.45% YoY from $15227.0 in Q1 2024.
Dyadic International (DYAI) Receivables - Other (2017 - 2025) Analysis & Trends
Dyadic International has reported Receivables - Other for 9 years, with the latest figure at $23213.0 in Q1 2025.
- Quarterly Receivables - Other rose 52.45% year-over-year to $23213.0 in Q1 2025, while the trailing twelve-month figure through Mar 2025 was $23213.0 (up 52.45% YoY) and the FY2024 annual result came in at $24248.0, up 140.48% from the prior year.
- Receivables - Other declined to $23213.0 in Q1 2025 per DYAI's latest filing, from $24248.0 in the prior quarter.
- Over five years, Receivables - Other peaked at $28.9 million in Q1 2022 and troughed at $9822.0 in Q3 2023.
- A 5-year average of $1.7 million and a median of $40835.0 in 2024 frame the typical range for Receivables - Other.
- The sharpest annual moves came in 2022 and 2023: Receivables - Other surged 18280.29% in 2022, then plunged 99.9% in 2023.
- Over 5 years, Receivables - Other stood at $94375.0 in 2021, then tumbled by 38.24% to $58285.0 in 2022, then sank by 82.7% to $10083.0 in 2023, then soared by 140.48% to $24248.0 in 2024, then retreated by 4.27% to $23213.0 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $23213.0, $24248.0, and $40835.0 for Q1 2025, Q4 2024, and Q3 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Dyadic International | 19.98 Mn | 19.98 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 23,213.00 |
| Mar 31, 2025 | 23,213.00 |
| Dec 31, 2024 | 24,248.00 |
| Dec 31, 2024 | 24,248.00 |
| Sep 30, 2024 | 40,835.00 |
| Sep 30, 2024 | 40,835.00 |
| Jun 30, 2024 | 28,160.00 |
| Jun 30, 2024 | 28,160.00 |
| Mar 31, 2024 | 15,227.00 |
| Mar 31, 2024 | 15,227.00 |
| Dec 31, 2023 | 10,083.00 |
| Dec 31, 2023 | 10,083.00 |
| Sep 30, 2023 | 9,822.00 |
| Sep 30, 2023 | 9,822.00 |
| Jun 30, 2023 | 36,053.00 |
| Jun 30, 2023 | 36,053.00 |
| Mar 31, 2023 | 30,078.00 |
| Mar 31, 2023 | 30,078.00 |
| Dec 31, 2022 | 58,285.00 |
| Dec 31, 2022 | 58,285.00 |